XML 19 R9.htm IDEA: XBRL DOCUMENT
v3.23.1

Condensed Consolidated Financial Statements Details | 3 Months Ended
--- | ---
Mar. 31, 2023
Condensed Consolidated Financial Statements Detail |
Condensed Consolidated Financial Statements Detail | 3. Condensed Consolidated Financial Statements Details Equity Securities Equity securities consisted of an investment in Rezolute’s common stock of $0.3 million for both March 31, 2023 and December 31, 2022 (Note 4). For the three months ended March 31, 2023 and 2022, the Company recognized a loss of $24,000 and $0.2 million, respectively, due to the change in fair value of its investment in Rezolute’s common stock in the other income (expense), net line item of the condensed consolidated statements of operations and comprehensive loss. Intangible assets, net The following table summarizes cost, accumulated amortization, and net carrying value of the intangible assets as of March 31, 2023 (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Accumulated | ​ | Net Carrying
​ | ​ | Cost | ​ | Amortization | ​ | Value
As of March 31, 2023 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Ebopiprant IP (Note 4) | ​ | $ | 15,247 | ​ | $ | 322 | ​ | $ | 14,925
Total intangible assets | ​ | $ | 15,247 | ​ | $ | 322 | ​ | $ | 14,925
​ The following table summarizes cost, accumulated amortization, and net carrying value of the intangible assets as of December 31, 2022 (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Accumulated | ​ | Net Carrying
​ | ​ | Cost | ​ | Amortization | ​ | Value
As of December 31, 2022 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Ebopiprant IP (Note 4) | ​ | $ | 15,247 | ​ | $ | 97 | ​ | $ | 15,150
Total intangible assets | ​ | $ | 15,247 | ​ | $ | 97 | ​ | $ | 15,150
​ The remaining life of the intangible assets is 16.7 years. The following table presents the projected amortization expense for the next five years (in thousands): ​
​ | ​ | ​ | ​
​ | ​ | Intangible Asset
​ |  | Amortization
​ |  | ​ | ​
2023 (excluding three months ended March 31, 2023) | ​ | $ | 673
2024 | ​ |  | 897
2025 | ​ |  | 897
2026 | ​ | ​ | 897
2027 | ​ | ​ | 897
Total | ​ | $ | 4,261
​ Accrued and Other Liabilities Accrued and other liabilities consisted of the following (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, | ​ | December 31,
​ |  | 2023 |  | 2022
Arbitration settlement costs (Note 9) | ​ |  | 4,132 | ​ |  | —
Accrued payroll, severance and retention costs | ​ |  | 1,087 | ​ |  | 1,449
Accrued legal and accounting fees | ​ | ​ | 504 | ​ | ​ | 867
Accrued incentive compensation | ​ | ​ | 304 | ​ | ​ | 562
Other accrued liabilities | ​ | ​ | 100 | ​ | ​ | 40
Total | ​ | $ | 6,127 | ​ | $ | 2,918
​ Net Loss Per Share Attributable to Common Stockholders The following is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31,
​ |  | 2023 |  | 2022
Numerator |  | ​ |  |  | ​ |
Net loss | ​ | $ | (9,813) | ​ | $ | (2,280)
Less: Series A accumulated dividends | ​ |  | (530) | ​ |  | (530)
Less: Series B accumulated dividends | ​ | ​ | (838) | ​ | ​ | (838)
Net loss attributable to common stockholders, basic and diluted | ​ | $ | (11,181) | ​ | ​ | (3,648)
​ | ​ | ​ | ​ | ​ |  | ​
Denominator | ​ |  | ​ | ​ |  | ​
Weighted average shares used in computing basic and diluted net loss per share attributable to common stockholders | ​ |  | 11,460 | ​ |  | 11,330
Basic and diluted net loss per share attributable to common stockholders | ​ | $ | (0.98) | ​ | $ | (0.32)
​ Potentially dilutive securities are excluded from the calculation of diluted net loss per share attributable to common stockholders if their inclusion is anti-dilutive. The following table shows the weighted-average shares from outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share attributable to common stockholders (in thousands): ​
​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31,
​ |  | 2023 |  | 2022
Convertible preferred stock | ​ | 5,003 | ​ | 5,003
Common stock options |  | 1,548 | ​ | 697
Warrants for common stock |  | 6 | ​ | 6
Total |  | 6,557 |  | 5,706
​

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Consolidated financial statement detail. + References No definition available. + Details
Name: | xoma_ConsolidatedFinancialStatementDetailAbstract
Namespace Prefix: | xoma_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration